AI assistant
SUPERDRY PLC — Regulatory Filings 2018
Nov 30, 2018
5316_rns_2018-11-30_c8c876bf-7261-4300-b68c-19205b214174.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0745J
Superdry PLC
30 November 2018
SuperdryPlc
("Superdry" or "the Company")
30 November 2018
Total Voting Rights
For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital at the date of this notice is 81,962,340 ordinary shares of 5p each, none of which are held in treasury.
The total number of voting rights in the Company is therefore 81,962,340.
The above figure of 81,962,340 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the FCA's Disclosure and Transparency Rules.
| For further information: | |
| Superdry Plc | |
| Simon Callander Company Secretary |
+44 (0) 1242 586643 [email protected] |
Notes to Editors
Superdry is a Global Digital Brand, obsessed with design, quality and fit and committed to relentless innovation. We design affordable, premium quality clothing, accessories and footwear which are sold around the world. We have a unique purpose to help our consumers feel amazing through wearing our clothes. We have a clear strategy for delivering continued growth via a disruptive multi-channel approach combining Ecommerce, Wholesale and physical stores. We operate in 59 countries, including our development markets of North America and China and have over 5,000 colleagues globally.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
TVRURUARWOAAOAA